NCT06607887 The Role of Postoperative Antibiotics in Laparoscopic Cholecystectomy
| NCT ID | NCT06607887 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Minia University Hospital |
| Condition | Infection Wound |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2024-08-30 |
| Primary Completion | 2024-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 300 participants in total. It began in 2024-08-30 with a primary completion date of 2024-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Comparison between postoperative parenteral prophylactic antibiotics, and oral antibiotics regarding the incidence of post laparoscopic cholecystectomy infection.
Eligibility Criteria
Inclusion Criteria: * Adult patients (aged above 18 years) undergoing laparoscopic cholecystectomy. Exclusion Criteria: * patients with comorbidities (Diabetes, malignancies, Immunosuppressed). Lost of follow-up. Patients received antibiotics within 72 hr before admission. Complicated cases involved, gangrenous and perforated cholecystitis and abscess.
Contact & Investigator
Asmaa A Elsayed, Ph.D.
PRINCIPAL INVESTIGATOR
Sohag University
Frequently Asked Questions
Who can join the NCT06607887 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Infection Wound. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT06607887 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT06607887 currently recruiting?
Yes, NCT06607887 is actively recruiting participants. Contact the research team at asmaa.abdelfattah@pharm.sohag.edu.eg for enrollment information.
Where is the NCT06607887 trial being conducted?
This trial is being conducted at Minya, Egypt.
Who is sponsoring the NCT06607887 clinical trial?
NCT06607887 is sponsored by Minia University Hospital. The principal investigator is Asmaa A Elsayed, Ph.D. at Sohag University. The trial plans to enroll 300 participants.